Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.023 | 1 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.023 | 1 | 0.5 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.017 | 0.3162 | 0.5 |
Toxoplasma gondii | cathepsin CPC1 | 0.023 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | FTZ F1 alpha | 0.017 | 0.3162 | 0.5 |
Brugia malayi | nuclear receptor NHR-88 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.017 | 0.3162 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.023 | 1 | 0.5 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.023 | 1 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | steroid hormone receptor | 0.017 | 0.3162 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | FTZ F1 alpha | 0.017 | 0.3162 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.017 | 0.3162 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.023 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | ecdysteroid receptor | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.017 | 0.3162 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.017 | 0.3162 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.023 | 1 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0143 | 0 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.017 | 0.3162 | 0.5 |
Onchocerca volvulus | 0.017 | 0.3162 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.017 | 0.3162 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.017 | 0.3162 | 0.5 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.3162 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.017 | 0.3162 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.